跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WELLVONE Atovaquone 250mg tablets - TGA Drug Approval Details
Approvals
/
TGA
/
WELLVONE Atovaquone 250mg tablets
Approved
STANDARD
WELLVONE Atovaquone 250mg tablets
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
50b71aa461222adf
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
50b71aa461222adf
Product Name
WELLVONE Atovaquone 250mg tablets
Artg Id
52264
Artg Name
WELLVONE Atovaquone 250mg tablet blister pack
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1995-05-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
50b71aa461222adf
Type
Standard
Back to TGA Approvals